TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27154871

Group type: EXPERIMENTAL
Intervention: Modified Qing'e Pill (MQEP)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Simulated pills (Control)
Number of subjects: 96
Study: 25146720

Group type: COMPARATOR
Intervention: CHOP chemotherapy
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: CHOP + bortezomib chemotherapy
Number of subjects: 46
Study: 22864529

Group type: EXPERIMENTAL
Intervention: Open mouth position
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Rubber dam with mouth open
Number of subjects: 20

Group type: COMPARATOR
Intervention: Mouth closed
Number of subjects: 20
Study: 21236451

Group type: EXPERIMENTAL
Intervention: Insulin treatment
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 23
Study: 18551362

Group type: EXPERIMENTAL
Intervention: Spiritual Meditation
Number of subjects: 83

Group type: COMPARATOR
Intervention: Internally Focused Secular Meditation
Number of subjects: 83

Group type: COMPARATOR
Intervention: Externally Focused Secular Meditation
Number of subjects: 83

Group type: COMPARATOR
Intervention: Muscle Relaxation
Number of subjects: 83
Study: 16439046

Group type: EXPERIMENTAL
Intervention: One visit Endodontic procedure
Number of subjects: 112

Group type: COMPARATOR
Intervention: Two visit Endodontic procedure
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Both interventions (one and two visits)
Number of subjects: 112
Study: 12646296

Group type: EXPERIMENTAL
Intervention: Enhanced care for females
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care for females
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enhanced care for males
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care for males
Number of subjects: 0
Study: 10845730

Group type: EXPERIMENTAL
Intervention: Levetiracetam 2000 mg daily
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Levetiracetam 4000 mg daily
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Placebo to Levetiracetam 4000 mg daily
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Levetiracetam 2000 mg daily (initiated)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Open-label phase (Levetiracetam 4000 mg daily)
Number of subjects: 119
Study: 9350938

Group type: EXPERIMENTAL
Intervention: <5 repetitive ventricular responses
Number of subjects: 149

Group type: COMPARATOR
Intervention: <16 repetitive ventricular responses
Number of subjects: 149
Study: 8416081

Group type: EXPERIMENTAL
Intervention: Standard tone stimuli at frequencies of 250, 1,000, or 4,000 Hz
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Deviant tone stimuli (10% higher frequency than standards)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Frequency dependence of MMNm source
Number of subjects: 0
Study: 3513587

Group type: EXPERIMENTAL
Intervention: Progesterone vaginal suppositories (200 mg in polyethylene glycol base), self-administered twice daily for a minimum of 12 days before menstruation for 3 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo, self-administered twice daily for a minimum of 12 days before menstruation for 3 months
Number of subjects: 20
Study: 31835649

Group type: EXPERIMENTAL
Intervention: Personal postal invitation letter
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Personal postal invitation letter with one reminder letter
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current screening practice (control)
Number of subjects: 0
Study: 30341135

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 1032

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 1032
Study: 27348693

Group type: EXPERIMENTAL
Intervention: Operative group (arthroscopic acromioplasty followed by structured exercise program)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Structured exercise group (non-operative treatment)
Number of subjects: 140
Study: 24991044

Group type: EXPERIMENTAL
Intervention: 25,000 IU neonatal vitamin A
Number of subjects: 6048

Group type: EXPERIMENTAL
Intervention: 50,000 IU neonatal vitamin A
Number of subjects: 6048

Group type: COMPARATOR
Intervention: Any dose of neonatal vitamin A (NVAS)
Number of subjects: 6048

Group type: COMPARATOR
Intervention: NVAS (any dose)
Number of subjects: 6048

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6048
Study: 22704229

Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TNA) administered preoperatively (1 g 10 minutes before surgery)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Tranexamic Acid (TNA) administered postoperatively
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (no TNA administration)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TNA) administered at different times during the procedure
Number of subjects: 107
Study: 20826629

Group type: EXPERIMENTAL
Intervention: Structured exercise (EX)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 100
Study: 19093655

Group type: EXPERIMENTAL
Intervention: Rapid palatal expansion (RPE) therapy
Number of subjects: 41
Study: 15746261

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO) at 5 ppm
Number of subjects: 274

Group type: COMPARATOR
Intervention: Control group (nonhypoxemic infants)
Number of subjects: 274
Study: 11897289

Group type: EXPERIMENTAL
Intervention: Qualitative descriptions of drug side-effects
Number of subjects: 750

Group type: COMPARATOR
Intervention: Quantitative descriptions of drug side-effects
Number of subjects: 750
Study: 9660282

Group type: COMPARATOR
Intervention: Prochlorperazine 10 mg i.v.
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg i.v.
Number of subjects: 64
Study: 8073244

Group type: EXPERIMENTAL
Intervention: Hypnosis administered by nurses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional oral medication combined with nerve blocks and/or spinal administration of drugs
Number of subjects: 0
Study: 2817597

Group type: EXPERIMENTAL
Intervention: LY171883 600 mg twice a day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 4901346

Group type: EXPERIMENTAL
Intervention: Ferro-Gradume (slow-release preparation of ferrous sulphate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ferrous fumarate (single daily dose regimen)
Number of subjects: 0
Study: 30920094

Group type: EXPERIMENTAL
Intervention: Self-affirmation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other-affirmation
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-affirmation (Control)
Number of subjects: 0
Study: 28325784

Group type: EXPERIMENTAL
Intervention: Combination of 1,100 mg myo‐inositol, 27.6 mg D‐chiro‐inositol, and 400 μg folic acid
Number of subjects: 240

Group type: COMPARATOR
Intervention: 400 μg folic acid only
Number of subjects: 240
Study: 25163832

Group type: EXPERIMENTAL
Intervention: If-then plans for mobility-related goals
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no if-then plans)
Number of subjects: 20
Study: 23478199

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided surgery (USS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Palpation-guided surgery (PGS)
Number of subjects: 0
Study: 22212270

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training program (walking and jogging) for 12 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 40
Study: 18165566

Group type: EXPERIMENTAL
Intervention: Propofol 2 mg/kg
Number of subjects: 340

Group type: COMPARATOR
Intervention: Thiopental 5 mg/kg
Number of subjects: 340
Study: 16984988

Group type: EXPERIMENTAL
Intervention: Octreotide LAR (20 mg)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (saline injections)
Number of subjects: 29
Study: 12875418

Group type: EXPERIMENTAL
Intervention: LocaLisa system
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional fluoroscopy-based approach
Number of subjects: 50
Study: 16972594

Group type: EXPERIMENTAL
Intervention: Batroxobin (1.0 ml (10BU) on days 1, 3, and 5; 0.5 ml (5BU) on days 7 and 9)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard (basic) therapy
Number of subjects: 90
Study: 10577646

Group type: EXPERIMENTAL
Intervention: Iodine‐123‐labelled iodoamphetamine single‐photon emission computed tomography
Number of subjects: 0
Study: 8742957

Group type: EXPERIMENTAL
Intervention: rHuEpo therapy during dialysis
Number of subjects: 91

Group type: COMPARATOR
Intervention: No rHuEpo therapy during dialysis
Number of subjects: 91
Study: 1892775

Group type: EXPERIMENTAL
Intervention: 3M (mitomycin C 7‐8 mg m‐2, mitozantrone 7‐8 mg m‐2, methotrexate 35 mg m‐2)
Number of subjects: 217

Group type: COMPARATOR
Intervention: VAC (vincristine 1.4 mg m‐2, anthracycline 30 mg m‐2, cyclophosphamide 400 mg m‐2)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: 3M
Number of subjects: 217
Study: 6638442

Group type: EXPERIMENTAL
Intervention: Althesin
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: methohexitone
Number of subjects: 120
Study: 31889508

Group type: EXPERIMENTAL
Intervention: Daily preventive zinc dispersible tablets (PZ; 7 mg zinc)
Number of subjects: 3407

Group type: EXPERIMENTAL
Intervention: Daily multiple micronutrient powders (MNP; 10 mg zinc, 6 mg iron, and 13 other micronutrients)
Number of subjects: 3407

Group type: EXPERIMENTAL
Intervention: Therapeutic zinc supplements for diarrhea treatment (TZ; 20 mg/day for 10 days)
Number of subjects: 3407

Group type: COMPARATOR
Intervention: Daily placebo powder
Number of subjects: 3407
Study: 29290273

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral program (reading an educational photo book and watching a music video)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (no cognitive-behavioral program)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral program
Number of subjects: 68
Study: 26409729

Group type: EXPERIMENTAL
Intervention: Digital pleural drainage device
Number of subjects: 172

Group type: COMPARATOR
Intervention: Analog pleural drainage device
Number of subjects: 172
Study: 24972577

Group type: EXPERIMENTAL
Intervention: Chinese medicine (CM) decoction based on syndrome differentiation
Number of subjects: 406

Group type: COMPARATOR
Intervention: Phenolphthalein Tablet (Control)
Number of subjects: 406

Group type: COMPARATOR
Intervention: Both groups (CM and Control)
Number of subjects: 406
Study: 21753728

Group type: EXPERIMENTAL
Intervention: Exercise and AA (EAA)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Exercise Alone (E)
Number of subjects: 51
Study: 19608563

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2%
Number of subjects: 65

Group type: COMPARATOR
Intervention: Ropivacaine 0.4%
Number of subjects: 65
Study: 17894656

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (20 mg/kg/day)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Untreated (control group)
Number of subjects: 43
Study: 15133359

Group type: EXPERIMENTAL
Intervention: Electrophysiology catheter aided positioning strategy (EPA)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Guiding catheter alone positioning strategy (GCA)
Number of subjects: 34
Study: 12411650

Group type: EXPERIMENTAL
Intervention: Acupuncture with stroke rehabilitation
Number of subjects: 1213

Group type: COMPARATOR
Intervention: Real acupuncture
Number of subjects: 1213

Group type: EXPERIMENTAL
Intervention: Acupuncture without stroke rehabilitation
Number of subjects: 1213
Study: 9849757

Group type: EXPERIMENTAL
Intervention: Reinforced pelvic floor muscle exercises (PFME) with physiotherapist instruction
Number of subjects: 230

Group type: COMPARATOR
Intervention: Standard postnatal pelvic floor muscle exercises
Number of subjects: 230
Study: 8006248

Group type: EXPERIMENTAL
Intervention: Brofaromine
Number of subjects: 51

Group type: COMPARATOR
Intervention: Lithium addition to maprotiline
Number of subjects: 51
Study: 2593866

Group type: EXPERIMENTAL
Intervention: Topical 17 beta-oestradiol (E2) applied twice daily for 45-50 days at concentrations of 0.1 mg/g and 1.0 mg/g
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo applied twice daily for 45-50 days
Number of subjects: 8
Study: 30925498

Group type: EXPERIMENTAL
Intervention: Add-on citalopram (30 mg/d)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Add-on lithium (adjusted to plasma levels)
Number of subjects: 104
Study: 29190863

Group type: EXPERIMENTAL
Intervention: Physical Activity Program (PAP) - 3 months, 5 days a week, 45 minutes each day
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no PAP)
Number of subjects: 22
Study: 25758426

Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed whey formula with L reuteri (PRO)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Partially hydrolyzed whey formula without L reuteri (CON)
Number of subjects: 122
Study: 23346990

Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg once daily for 12 weeks
Number of subjects: 511

Group type: COMPARATOR
Intervention: Tamsulosin 0.4 mg once daily for 12 weeks
Number of subjects: 511

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 511
Study: 21482964

Group type: EXPERIMENTAL
Intervention: High-dose multivitamin (folic acid, vitamin B6, and vitamin B12)
Number of subjects: 4110

Group type: COMPARATOR
Intervention: Low-dose multivitamin (folic acid, vitamin B6, and vitamin B12)
Number of subjects: 4110
Study: 20382685

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (100 mg/d)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Diabetic patients
Number of subjects: 175
Study: 17971602

Group type: EXPERIMENTAL
Intervention: New therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 0
Study: 16272869

Group type: EXPERIMENTAL
Intervention: Standard antituberculous chemotherapy for 6 or 12 months
Number of subjects: 56
Study: 12171372

Group type: EXPERIMENTAL
Intervention: Family intervention (single family therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other active interventions
Number of subjects: 0
Study: 10187880

Group type: EXPERIMENTAL
Intervention: Extracorporeal rheopheresis
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (no extracorporeal rheopheresis)
Number of subjects: 33
Study: 7482410

Group type: EXPERIMENTAL
Intervention: aprotinin treatment (A)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 16
Study: 2405506

Group type: EXPERIMENTAL
Intervention: HCG injections
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo injections (saline)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HCG injections and Placebo injections
Number of subjects: 40